Addressing benzene contamination, FDA issues guidance for reformulating products containing certain carbomers

In response to a series of alarming studies and citizen petitions regarding benzene contamination, the FDA requested removal of five specific United States Pharmacopeia (USP) monographs for carbomer ingredients containing high amounts of benzene. Now, the FDA has released guidance laying out the tests and regulatory submissions needed for the reformulation of products containing these ingredients.

Fill out the form to read the full article.

Required *

Copy link
Powered by Social Snap